logo-loader
ASX:PAR

Paradigm Biopharmaceuticals Ltd

Receive alerts
Market:
ASX
Price
0.38 AUD
Day Change
1.35%
Market Cap:
$131.7 m
52 weeks high
1.68
52 weeks low
0.32

In brief

Paradigm Biopharmaceuticals Ltd (ASX:PAR) is a drug repurposing company driven by core competencies and experience at board and executive level in clinical and commercial pharmaceutical development.

The company’s approach is to take an existing approved drug, which has demonstrated safety in its approved indications, and repurposing the drug in a new patented therapeutic application.

Paradigm’s pipeline indications cover the use of pharmaceutical compound Pentosan Polysulfate Sodium (PPS), supported by full patent and IP protection and its immediate commercial focus is the repurposing of PPS for the treatment of Osteoarthritis (OA).